Trending...
- Seligson Law Launches New Website to Support Cannabis Businesses in California and New York - 110
- General Auction Company Announces August 8th Auction- Now Accepting Consignments - 102
- FTE Networks, Inc Shareholders Elect New Board of Directors
SACRAMENTO, Calif. - Californer -- The ROS1ders, a global group of patients and caregivers living with ROS1+ cancer, announced the recipients of the 2024 ROS1+ Cancer Innovation Award. Funds for the awards were raised through individual contributions to The ROS1ders by patients and supporters. Each award carries a one-year, $75,000 seed grant to fund high-risk, high-reward research projects in ROS1+ cancer.
The recipients of the 2024 ROS1+ Cancer Innovation Awards are:
More on The Californer
About The ROS1ders
The ROS1ders is the largest global group of patients and family members living with ROS1+ cancer. It seeks to improve outcomes for all ROS1+ cancers through community, education, and research. Membership in their private Facebook group exceeds 2000 people from over 50 countries. The nonprofit is internationally recognized in the oncology and patient advocacy communities as experts in their disease. Its resources include a medically-vetted website and collaborations with international ROS1+ clinicians, researchers and industry. Please visit theros1ders.org to learn more.
About ROS1+ Cancer
More on The Californer
The recipients of the 2024 ROS1+ Cancer Innovation Awards are:
- Monte Winslow, PhD, Dmitri A. Petrov, PhD and Joel Neal, MD, PhD, Stanford University School of Medicine – Towards precision medicine for oncogenic ROS1 fusion driven lung cancer
This project will create models of each known ROS1 fusion variant and investigate how they influence cancer development and treatment responses. - Jaime Schneider, MD, PhD, Massachusetts General Hospital – Identifying Metabolic Vulnerabilities in ROS1+ Lung Cancer
This project aims to shed light on metabolic pathways that may contribute to acquired resistance to treatments for ROS1+ cancer, with the goal of identifying new targets for treatments that may prevent or treat resistance mechanisms.
More on The Californer
- New York-based Futurist Wins Dual Honors at The Speaker Awards 2025
- Reddit, Inc. (RDDT) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
- Magic Data Recovery Released 2025 Advanced File Recovery Tool for Windows Users
- Swim Up Hill Foundation Celebrates Jamal Hill's Story in Peacock Original Series "ADAPTIVE"
About The ROS1ders
The ROS1ders is the largest global group of patients and family members living with ROS1+ cancer. It seeks to improve outcomes for all ROS1+ cancers through community, education, and research. Membership in their private Facebook group exceeds 2000 people from over 50 countries. The nonprofit is internationally recognized in the oncology and patient advocacy communities as experts in their disease. Its resources include a medically-vetted website and collaborations with international ROS1+ clinicians, researchers and industry. Please visit theros1ders.org to learn more.
About ROS1+ Cancer
- ROS1+ cancer is relatively rare, occurring in just 1-2% of non-small cell lung cancer. The incidence is thought to be similar in other types of cancer.
- Biomarker testing for ROS1 fusions is recommended in guidelines for non-small cell lung cancer, but few other cancers, yet.
- Patients typically have adenocarcinoma NSCLC, a younger age than the average NSCLC patient, and no smoking history (a smoking history should not exclude patients from biomarker testing or targeted therapies).
- Oral targeted therapies are the recommended first-line treatment for metastatic ROS1+ NSCLC and have increased the survival of patients by years. However, these drugs eventually stop working due to acquired resistance. The mechanisms of resistance are not well understood.
More on The Californer
- New Jersey Unveils Official Portrait of Former Lt. Governor Kim Guadagno, Mercy Center President & CEO
- Athabasca University Elevates its Learning Environment with PebblePad
- Proyecto de Singapur Rejuvenecimiento de Mandai
- IQSTEL (N A S D A Q: IQST) Surging Past Mid-Year Revenue Goals with $128.8M, Eyes $400M Run Rate and $1B Future; Analyst Coverage Targeting $18-$22
- Academy Award Honoree and Multi-Emmy Winner Debbie Allen to Deliver Keynote at CommHIT25 at Kennedy Space Center
Source: The ROS1ders, Inc.
0 Comments
Latest on The Californer
- Anunnaki: Origin of Sumeria | Now Available on Filmzie via Roku-Enabled Television
- BeyondTrucks Doubles Down on AI Investment with Hire of MIT PhD and Former Noodle.ai Chief Product Officer
- TORmem Unveils Revolutionary Memory Disaggregation Platform for AI Infrastructure
- Introducing Red Bear Ventures (RBV), A New Community-First Investment Platform Investing Exclusively in Cornell-Affiliated Companies
- The Ferryman's Toll Officially Launched
- Health & Wellness Emerge as Wall Street's Ultimate Strategic Asset, Reshaping Competitive Landscape with CourMed at the Forefront
- DRGx Design Research Group Partners with Electric Moss to Pioneer Next-Generation Wellness Solutions
- Brain Behind Kenya's Hustler Fund Now Leading Charge to Establish United African Defence Force & Unified Maritime Border
- California prepositions resources in Plumas and Sierra Counties ahead of critical fire weather conditions
- Attar Bashi USA Launches with a Mission to Promote Wellness Through Handcrafted Herbal Teas
- Order Tramadol Online Without A Prescription
- California: Governor Newsom and Acting Governor Kounalakis honor fallen Los Angeles County Sheriff's Department Detectives
- Silva Construction Explains How to Maximize Curb Appeal Through Strategic Exterior Renovations
- Food Journal Magazine Launches as the Ultimate Guide to Food Festivals and Culinary Culture
- Prestige Commercial Capital Unveils CoreRate Preferred Funding for Small Business Growth in 2025
- Order Ivermectin Online now and get a physician prescribed supply delivered directly to you
- Become a Founding Flamekeeper: Lifetime Access Now Open for a Limited Time
- Ignazio Arces Wins Silver Stevie Award in New York as Culture Transformation Leader of the Year
- 2025 ESPY After Party Brings Together Celebrities, Athletes, and Industry Power Players at Skybar
- Open Sauce's Eye-catching Creations? Meet Elegoo's AI Robots, Glowing Cosplay Wings, and More, All 3D Printed